Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 31 Dec ‘20 |
|
|---|---|---|---|---|---|
| $44.4M | $93.1M | $48.8M | 57.9% |
|
|
| $44.2M | $163M | $119M | 80.4% |
|
|
| $43.6M | $1.21B | $1.17B | 21.9% |
|
|
254
Ultragenyx Pharmaceutical
RARE
$2.29B
| $43.4M | $59.6M | $16.3M | 83.2% |
|
| $43.3M | $48.6M | $5.35M | 6.22% |
|
|
| $43.3M | $202M | $159M | 139% |
|
|
| $43M | $154M | $111M | 35.3% |
|
|
| $42.8M | $45.9M | $3.16M | 220% |
|
|
| $42.6M | $206M | $164M | 73.1% |
|
|
| $42.2M | $63.3M | $21M | 60% |
|
|
261
Iovance Biotherapeutics
IOVA
$1.52B
| $42M | $120M | $77.8M | 92% |
|
| $41.3M | $197M | $156M | 109% |
|
|
| $40.4M | $104M | $63.5M | 114% |
|
|
| $40.2M | $41.6M | $1.34M | 146% |
|
|
| $40.1M | $88M | $47.8M | 1.05% |
|
|
| $40M | $70.6M | $30.5M | 68.8% |
|
|
| $39M | $151M | $112M | 284% |
|
|
| $39M | $128M | $88.8M | 74.4% |
|
|
| $38.9M | $62.6M | $23.7M | 96.2% |
|
|
| $38.8M | $56.4M | $17.5M | 98.2% |
|
|
| $38.6M | $63.7M | $25.1M | 270% |
|
|
| $37.6M | $39.3M | $1.74M | 112% |
|
|
| $37.1M | $66.8M | $29.7M | 37.8% |
|
|
| $37.1M | $48M | $10.9M | 56.2% |
|
|
| $36.7M | $127M | $90.1M | 57.1% |
|